In the c-myc/TGF-α transgenic mouse model, activation of ß-catenin through phenobarbital treatment was shown to provide an invasive advantage to the tumours, where a cytoplasmic relocalisation of E-cadherin was observed [77]. This evidence concerns the gene CDH1 and neoplasm.